Rapid clearance of insulin-like growth factor (IGF)-binding protein species from blood and an associated fall in circulating IGF-I following partial hepatectomy in the rat

• Published in: Journal of endocrinology Vol. 137; no. 2; pp. 271 - 280
• Main Authors: PHILLIPS, I. D, ARANY, E, STRAIN, A. J, HAN, V. K. M, HILL, D. J
• Format: Journal Article
• Language: English
• Published: Colchester BioScientifica 01.05.1993; Portland Press
• Subjects: Analytical, structural and metabolic biochemistry; Animals; Biological and medical sciences; Blood Glucose - metabolism; Blotting, Northern; Blotting, Western; Carrier Proteins - metabolism; Fundamental and applied biological sciences. Psychology; Hepatectomy; Insulin - metabolism; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I - metabolism; Liver - metabolism; Male; Protein hormones. Growth factors. Cytokines; Proteins; Radioimmunoassay; Rats; Rats, Wistar; Somatomedins - metabolism; Time Factors; Insulin like growth factor binding protein; Binding protein; Vertebrata; Mammalia; Rat; Somatomedin C; Liver; Rodentia; Clearance; Growth factor; Hepatectomy
• ISSN: 0022-0795; 1479-6805
• DOI: 10.1677/joe.0.1370271

ABSTRACT The presence of insulin-like growth factors (IGFs) in blood is regulated by their association with specific IGF-binding proteins (IGFBPs). In turn, the level of IGFBPs in the blood is likely to depend on a dynamic equilibrium between peptide production and clearance to extravascular tissues or organ-specific degradation. Since circulating IGFBPs may largely derive from liver we have employed partial hepatectomy in the rat to study the clearance rate of endogenous IGFBPs from blood once a major site of production is removed. Adult male rats were partially hepatectomized and serum and the remaining liver removed between 30 min and 7 days after surgery. Ligand blot analysis revealed two major species of IGFBP, of 28–30 kDa and 40–44 kDa in sera from control rats or sham-operated rats respectively. The larger species corresponded in size to rat IGFBP-3, but the smaller form was not recognized by antisera against rat IGFBP-1, bovine IGFBP-2 or human IGFBP-5 following Western immunoblot. Following hepatectomy, the levels of both IGFBP forms in the serum declined within 30 min and were barely detectable after 3 h or 6 h. They began to increase again in serum 24 h following surgery. The reduction in IGFBPs following hepatectomy was not primarily due to degradation by specific proteases in serum. Circulating levels of insulin were increased fivefold 3 h after hepatectomy but subsequently returned to control values. The rise in insulin was accompanied by a significant (P < 0·05) reduction in circulating IGF-I after 3 h which persisted at 24 h. Glucose levels in serum showed a transient but non-significant reduction between 90 min and 6 h after hepatectomy. Total RNA was extracted from remnant liver and subjected to Northern blot hybridization with 32P-labelled cDNAs encoding rat IGFBP-1, -2 or -3. Messenger RNA encoding IGFBP-1 was barely detectable in liver from control or sham-operated animals, but increased within 30 min of partial hepatectomy and peaked at 3 h. It subsequently declined and was again barely detectable after 24 h. No expression of IGFBP-2 or -3 mRNAs was found by Northern blot analysis in the liver of control animals or following partial hepatectomy. These results suggest that both IGF-I and IGFBPs in rat serum decreased rapidly following partial hepatectomy, and that this was due largely to the rapid clearance of the peptide and its binding proteins once the major source of production was removed. A rapid induction of IGFBP-1 in the remaining liver may be unrelated to the circulating IGFBPs since immunoreactive IGFBP-1 was not detected in rat serum. Journal of Endocrinology (1993) 137, 271–280